BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1907028)

  • 1. Pathogenesis of hepatic steatosis during total parenteral nutrition.
    Nussbaum MS; Fischer JE
    Surg Annu; 1991; 23 Pt 2():1-11. PubMed ID: 1907028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.
    Li SJ; Nussbaum MS; McFadden DW; Gapen CL; Dayal R; Fischer JE
    Surgery; 1988 Aug; 104(2):350-7. PubMed ID: 3135627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.
    Sax HC; Talamini MA; Brackett K; Fischer JE
    Surgery; 1986 Oct; 100(4):697-704. PubMed ID: 3094186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats.
    Li SJ; Nussbaum MS; McFadden DW; Zhang FS; LaFrance RJ; Dayal R; Fischer JE
    J Surg Res; 1990 May; 48(5):421-6. PubMed ID: 2112667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on therapeutic effect of carnitine on hepatic steatosis caused by total parenteral nutrition in rats].
    Liang L; Luo S; Zheng J; Huang J
    Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):500-2, 33. PubMed ID: 11829901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN).
    Li SJ; Nussbaum MS; McFadden DW; Dayal R; Fischer JE
    J Surg Res; 1989 Jun; 46(6):557-66. PubMed ID: 2499733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio.
    Nussbaum MS; Li S; Bower RH; McFadden DW; Dayal R; Fischer JE
    JPEN J Parenter Enteral Nutr; 1992; 16(2):106-9. PubMed ID: 1556803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential nature of choline with implications for total parenteral nutrition.
    Shronts EP
    J Am Diet Assoc; 1997 Jun; 97(6):639-46, 649; quiz 647-8. PubMed ID: 9183326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lipid-supplemented total parenteral nutrition on fatty liver disease in a premature neonatal piglet model.
    Hyde MJ; Amusquivar E; Laws J; Corson AM; Geering RR; Lean IJ; Putet G; Dodds PF; Herrera E; Clarke L
    Neonatology; 2008; 93(2):77-86. PubMed ID: 17684422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric total parenteral nutrition. Liver histopathology.
    Cohen C; Olsen MM
    Arch Pathol Lab Med; 1981 Mar; 105(3):152-6. PubMed ID: 6781446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary abnormalities associated with total parenteral nutrition.
    Klein S; Nealon WH
    Semin Liver Dis; 1988 Aug; 8(3):237-46. PubMed ID: 3148193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of nitric oxide on hepatic steatosis induced by total parenteral nutrition in rats.
    Zheng JF; Wang HD; Liang LJ
    Acta Pharmacol Sin; 2002 Sep; 23(9):824-8. PubMed ID: 12230952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of administration of fat emulsion: hepatic changes in infant rats receiving total parenteral nutrition with and without fat.
    Oshita M; Takehara H; Yamaguchi M; Doi K; Ueda N; Naito S; Hiraoka I; Tashiro S
    Clin Nutr; 2004 Oct; 23(5):1060-8. PubMed ID: 15380896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic complications in parenteral nutrition].
    Müller MJ
    Z Gastroenterol; 1996 Jan; 34(1):36-40. PubMed ID: 8776174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of liver complications in children receiving long-term parenteral nutrition.
    Peyret B; Collardeau S; Touzet S; Loras-Duclaux I; Yantren H; Michalski MC; Chaix J; Restier-Miron L; Bouvier R; Lachaux A; Peretti N
    Eur J Clin Nutr; 2011 Jun; 65(6):743-9. PubMed ID: 21427734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
    García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
    Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.
    Pappo I; Bercovier H; Berry E; Gallilly R; Feigin E; Freund HR
    JPEN J Parenter Enteral Nutr; 1995; 19(1):80-2. PubMed ID: 7658606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary abnormalities associated with total parenteral nutrition.
    Fisher RL
    Gastroenterol Clin North Am; 1989 Sep; 18(3):645-66. PubMed ID: 2509358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of parenteral and enteral hyperalimentation on hepatic drug metabolism in the rat.
    Knodell RG; Steele NM; Cerra FB; Gross JB; Solomon TE
    J Pharmacol Exp Ther; 1984 May; 229(2):589-97. PubMed ID: 6425494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.